L-type and R-type voltage-gated calcium channels (LTCC and RTCC)

L-type and R-type voltage-gated calcium channels (VGCCs) are essential transmembrane proteins that facilitate the influx of calcium ions into excitable cells upon membrane depolarization. L-type channels, comprising the Cav1 family (Cav1.1–Cav1.4), are predominantly found in cardiac and smooth muscle, where they trigger contraction, and in neurons, where they regulate gene expression and excitability [7, 18]. R-type channels, specifically the Cav2.3 isoform, are primarily localized in the central nervous system and play key roles in neurotransmitter release, synaptic plasticity, and the modulation of pain signals [11, 15]. These channels are significant therapeutic targets; L-type blockers like amlodipine and nifedipine are cornerstones in treating hypertension and angina, while R-type channels are implicated in the pathophysiology of epilepsy and are targeted by certain anticonvulsants like lamotrigine [1, 8, 16]. Mutations in the genes encoding these channels, such as CACNA1C and CACNA1E, are associated with severe conditions like Timothy syndrome and developmental epileptic encephalopathy [13, 15]. Pharmacological modulation of these channels allows for the control of cardiovascular tone and neuronal firing rates, though it requires careful management of side effects like hypotension or cardiac conduction delays [4, 8].

Other names

Cav1 and Cav2.3 channelsHigh-voltage activated calcium channelsDHP-sensitive and residual calcium channelsVoltage-dependent calcium channels (L and R types)

Blockade of the pore-forming alpha-1 subunits (Cav1.x and Cav2.3) to inhibit calcium ion influx in response to membrane depolarization, thereby reducing cellular contractility or neuronal excitability.